Tim Schleimer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tim Schleimer has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Svenja Kaczorowski
Department of Nursing, Midwifery and Therapeutic Sciences, Division of Physiotherapy, Bochum University of Applied Sciences, Bochum, Germany
3 shared publications - Tobias Saueressig
Physio Meets Science GmbH, Leimen, Germany
3 shared publications - Alessandro Chiarotto
Department of General Practice, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
2 shared publications - Andrew John Hahne
Discipline of Physiotherapy, School of Allied Health, Human Services & Sport, La Trobe University, Bundoora, Victoria, Australia
2 shared publications - Clint Thomas Miller
Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia
2 shared publications - Daniel Ludovic Belavy
Fachbereich Pflege-, Hebammen- und Therapiewissenschaften (PHT), Hochschule Bochum, Bochum, Germany
2 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by BMJ in British Journal of Sports Medicine
Optimal exercise dose in adults with chronic low back pain disorders: systematic review with dose-response network meta-analysis
Objective: To quantify exercise dose-response relationships and estimate the optimal dose in adults with chronic low back pain disorders (CLBDs). Design: Systematic review with random-effects model-based (non-linear) dose-response network meta-analysis. Risk of bias was assessed with Cochrane RoB 2 and certainty with the minimally contextualised Grading of Recommendations, Assessment, Development and Evaluation framework. A ≥5-point change (scaled 0–100) was predefined as clinically meaningful. Data sources: Six databases, two trial registries and citations were searched to 3 June 2025 Eligibility criteria: Randomised controlled trials of exercise in adults (≥18 years) with CLBDs assessing disability or back pain at short (>1 day and ≤3 months), intermediate (>3 months and<12 months) and long-term (≥12 months) follow-up. Results: We included 239 trials (252 reports); 99.2% included non-specific chronic low back pain; two trials included radicular presentations. The model-predicted optimal dose for short-term disability was 4 sessions/week, 25 min/session over 13 weeks. For short-term pain intensity, the optimal dose was 3 sessions/week, 30 min/session over 8 weeks. However, credible intervals of most dose-levels overlapped. Few dose combinations were clinically meaningful beyond the short term. 84% of trials were at high risk of bias and certainty was very low to low. Adverse events (reported in 28.5% of trials) were predominantly non-serious and musculoskeletal. Conclusions: Exercise training delivered at low to moderate doses was associated with short-term improvements in disability and pain intensity, which may be clinically meaningful, with limited additional benefit at higher exposure. Model-predicted doses provide guidance for exercise prescription; but the available evidence does not support a single optimal exercise dose and should be interpreted with caution given the low to very low certainty of evidence. Exercise training for radicular presentations is a key evidence gap.
- 24 September 2026
- Published by BMJ in British Journal of Sports Medicine
Open AccessOptimal exercise dose in adults with chronic low back pain disorders: systematic review with dose-response network meta-analysis
Objective: To quantify exercise dose-response relationships and estimate the optimal dose in adults with chronic low back pain disorders (CLBDs). Design: Systematic review with random-effects model-based (non-linear) dose-response network meta-analysis. Risk of bias was assessed with Cochrane RoB 2 and certainty with the minimally contextualised Grading of Recommendations, Assessment, Development and Evaluation framework. A ≥5-point change (scaled 0–100) was predefined as clinically meaningful. Data sources: Six databases, two trial registries and citations were searched to 3 June 2025 Eligibility criteria: Randomised controlled trials of exercise in adults (≥18 years) with CLBDs assessing disability or back pain at short (>1 day and ≤3 months), intermediate (>3 months and<12 months) and long-term (≥12 months) follow-up. Results: We included 239 trials (252 reports); 99.2% included non-specific chronic low back pain; two trials included radicular presentations. The model-predicted optimal dose for short-term disability was 4 sessions/week, 25 min/session over 13 weeks. For short-term pain intensity, the optimal dose was 3 sessions/week, 30 min/session over 8 weeks. However, credible intervals of most dose-levels overlapped. Few dose combinations were clinically meaningful beyond the short term. 84% of trials were at high risk of bias and certainty was very low to low. Adverse events (reported in 28.5% of trials) were predominantly non-serious and musculoskeletal. Conclusions: Exercise training delivered at low to moderate doses was associated with short-term improvements in disability and pain intensity, which may be clinically meaningful, with limited additional benefit at higher exposure. Model-predicted doses provide guidance for exercise prescription; but the available evidence does not support a single optimal exercise dose and should be interpreted with caution given the low to very low certainty of evidence. Exercise training for radicular presentations is a key evidence gap.
- Open Access
- 23 July 2026
- Published by BMJ in BMJ Evidence-Based Medicine
Defining and interpreting the clinical relevance of intervention effects for patient-reported outcomes: the smallest worthwhile effect construct
In clinical research, statistically significant effects do not necessarily indicate that an intervention provides benefits that are meaningful to patients. This is particularly important for patient-reported outcomes, where thresholds used to interpret clinical relevance are often derived from within-person changes, such as the minimal clinically important difference, and then inappropriately applied to between-group effects in randomised trials and meta-analyses. This article clarifies the conceptual distinction between within-group change and between-group effects, and argues that the latter should be the focus when judging the comparative value of healthcare interventions. We introduce the smallest worthwhile effect (SWE) as a patient-centred, intervention-specific construct representing the smallest between-group effect of an intervention over a comparator that patients consider worthwhile when weighed against harms, costs and other inconveniences. We describe the main methods used to estimate the SWE, including benefit-harm trade-off studies and discrete choice experiments, and illustrate its application by reinterpreting a randomised trial of physiotherapy for low back pain and a meta-analysis of discectomy versus non-surgical care for sciatica. We also show how the SWE can inform judgements of imprecision within the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework, offering a patient-derived threshold for distinguishing trivial from worthwhile effects. By focusing on patient-derived thresholds rather than arbitrary statistical or within-group approaches, the SWE construct can help researchers, clinicians and other stakeholders make more transparent and meaningful judgements about the worthwhileness of compared healthcare interventions from a patient perspective.
- 23 July 2026
- Published by BMJ in BMJ Evidence-Based Medicine
Open AccessDefining and interpreting the clinical relevance of intervention effects for patient-reported outcomes: the smallest worthwhile effect construct
In clinical research, statistically significant effects do not necessarily indicate that an intervention provides benefits that are meaningful to patients. This is particularly important for patient-reported outcomes, where thresholds used to interpret clinical relevance are often derived from within-person changes, such as the minimal clinically important difference, and then inappropriately applied to between-group effects in randomised trials and meta-analyses. This article clarifies the conceptual distinction between within-group change and between-group effects, and argues that the latter should be the focus when judging the comparative value of healthcare interventions. We introduce the smallest worthwhile effect (SWE) as a patient-centred, intervention-specific construct representing the smallest between-group effect of an intervention over a comparator that patients consider worthwhile when weighed against harms, costs and other inconveniences. We describe the main methods used to estimate the SWE, including benefit-harm trade-off studies and discrete choice experiments, and illustrate its application by reinterpreting a randomised trial of physiotherapy for low back pain and a meta-analysis of discectomy versus non-surgical care for sciatica. We also show how the SWE can inform judgements of imprecision within the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework, offering a patient-derived threshold for distinguishing trivial from worthwhile effects. By focusing on patient-derived thresholds rather than arbitrary statistical or within-group approaches, the SWE construct can help researchers, clinicians and other stakeholders make more transparent and meaningful judgements about the worthwhileness of compared healthcare interventions from a patient perspective.
- Open Access
- 30 June 2026
- Published by BMJ in BMJ Medicine
- Vol. 5 (1) , e001908
Conservative treatments for chronic non-specific low back pain: time course network meta-analysis
Objective: To examine the efficacy of conservative (non-surgical) treatments, usual care, and no treatment for chronic radicular and non-specific back pain. Design: Time course network meta-analysis. Data sources: Six electronic databases (Medline, SPORTDiscus, CINAHL, PsycINFO, Embase, and CENTRAL), searched from inception to 24 July 2020, and 302 previous systematic reviews. Eligibility criteria for selecting studies: Full peer reviewed publications in English or German of randomised controlled trials, randomised clinical trials, randomised controlled cluster trials, or randomised crossover trials in adults (aged ≥18 years) receiving common conservative treatments for non-specific and radicular chronic low back pain. Treatments examined were acupuncture, education or advice, electrotherapy (including heat and ice electrotherapeutic modalities applied non-invasively), exercise training, manual treatments or manipulation, massage, the McKenzie method, pharmacotherapy, psychological treatments, traction, physical therapy (otherwise not falling into specific treatment combinations), placebo, multidisciplinary pain management, usual care (eg, management by a doctor), and no treatment (true control). Results: Back pain intensity, leg pain intensity, disability, and mental health outcomes were reported immediately (3 and <12 months), and long term (≥12 months) time points. 581 reports of 551 studies (71 126 patients) were included. 510 trials included people with non-specific chronic low back pain and 41 trials included those with radicular chronic low back pain. For back pain (0-100 scale), acupuncture (mean difference −20.91, 95% credible interval −24.00 to −11.95), electrotherapy (−18.98, −21.84 to−10.95), exercise (−15.59, −17.51 to −10.05), manual treatment (−19.48, −22.17 to −11.74), massage (−25.61, −30.42 to −10.91), and multidisciplinary pain management (−18.96, −22.26 to −9.58) exceeded the minimal clinically important difference (set at 0.5 standard deviation) in the short term. For disability (0-100 scale), acupuncture (mean difference −10.52, 95% credible intervals −11.84 to −6.59), massage (−9.95, −11.45 to −5.50), and multidisciplinary pain management (−12.56, −13.91 to −8.55) were clinically effective in the short term. In the immediate and intermediate term only, the McKenzie method and massage, respectively, exceeded the minimal clinically important difference. In the long term, although two of the 14 treatments for back pain and nine of 14 treatments for disability had statistically significant benefits compared with no treatment, the effects were not clinically significant. The certainty of the evidence based on the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) framework was low (1.4%) to very low (98.6%) across interventions and time points. Findings for massage and the McKenzie method were not stable in the sensitivity analyses. Treatment effects for radicular chronic low back pain did not seem to differ from those for non-specific chronic low back pain. Conclusions: Some treatments were effective for pain and function in non-specific chronic low back pain, but improvements did not persist long term. Most of the evidence was for non-specific chronic low back pain; the evidence base for radicular chronic low back pain was limited. Although sensitivity analyses did not provide evidence for a different response in radicular chronic low back pain, an evidence gap remains for this subpopulation. Future work should explore strategies to establish the long term efficacy of modifications to lifestyle and behaviour. Systematic review registration: PROSPERO CRD42020182039
- 30 June 2026
- Published by BMJ in BMJ Medicine
- Vol. 5 (1) , e001908
Open AccessConservative treatments for chronic non-specific low back pain: time course network meta-analysis
Objective: To examine the efficacy of conservative (non-surgical) treatments, usual care, and no treatment for chronic radicular and non-specific back pain. Design: Time course network meta-analysis. Data sources: Six electronic databases (Medline, SPORTDiscus, CINAHL, PsycINFO, Embase, and CENTRAL), searched from inception to 24 July 2020, and 302 previous systematic reviews. Eligibility criteria for selecting studies: Full peer reviewed publications in English or German of randomised controlled trials, randomised clinical trials, randomised controlled cluster trials, or randomised crossover trials in adults (aged ≥18 years) receiving common conservative treatments for non-specific and radicular chronic low back pain. Treatments examined were acupuncture, education or advice, electrotherapy (including heat and ice electrotherapeutic modalities applied non-invasively), exercise training, manual treatments or manipulation, massage, the McKenzie method, pharmacotherapy, psychological treatments, traction, physical therapy (otherwise not falling into specific treatment combinations), placebo, multidisciplinary pain management, usual care (eg, management by a doctor), and no treatment (true control). Results: Back pain intensity, leg pain intensity, disability, and mental health outcomes were reported immediately (3 and <12 months), and long term (≥12 months) time points. 581 reports of 551 studies (71 126 patients) were included. 510 trials included people with non-specific chronic low back pain and 41 trials included those with radicular chronic low back pain. For back pain (0-100 scale), acupuncture (mean difference −20.91, 95% credible interval −24.00 to −11.95), electrotherapy (−18.98, −21.84 to−10.95), exercise (−15.59, −17.51 to −10.05), manual treatment (−19.48, −22.17 to −11.74), massage (−25.61, −30.42 to −10.91), and multidisciplinary pain management (−18.96, −22.26 to −9.58) exceeded the minimal clinically important difference (set at 0.5 standard deviation) in the short term. For disability (0-100 scale), acupuncture (mean difference −10.52, 95% credible intervals −11.84 to −6.59), massage (−9.95, −11.45 to −5.50), and multidisciplinary pain management (−12.56, −13.91 to −8.55) were clinically effective in the short term. In the immediate and intermediate term only, the McKenzie method and massage, respectively, exceeded the minimal clinically important difference. In the long term, although two of the 14 treatments for back pain and nine of 14 treatments for disability had statistically significant benefits compared with no treatment, the effects were not clinically significant. The certainty of the evidence based on the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) framework was low (1.4%) to very low (98.6%) across interventions and time points. Findings for massage and the McKenzie method were not stable in the sensitivity analyses. Treatment effects for radicular chronic low back pain did not seem to differ from those for non-specific chronic low back pain. Conclusions: Some treatments were effective for pain and function in non-specific chronic low back pain, but improvements did not persist long term. Most of the evidence was for non-specific chronic low back pain; the evidence base for radicular chronic low back pain was limited. Although sensitivity analyses did not provide evidence for a different response in radicular chronic low back pain, an evidence gap remains for this subpopulation. Future work should explore strategies to establish the long term efficacy of modifications to lifestyle and behaviour. Systematic review registration: PROSPERO CRD42020182039
- Top Cited PapersOpen Access
Effectiveness of exercise therapy for osteoarthritis: an overview of systematic reviews and randomised controlled trials
Objective: To provide an overview of the effects of exercise for osteoarthritis. Design: Overview. Data sources: Medline, Embase, Epistemonikos, PEDro, Cochrane and registries from inception to 8 November 2025. Eligibility criteria: Reviews comparing exercise with placebo, no intervention or other interventions on pain and function for osteoarthritis. Supplementary trials were included to update inconclusive areas. Data extraction and synthesis: Two independent reviewers extracted data and assessed bias. Data were standardised to a 0–100 scale and reanalysed using random-effects meta-analysis. Certainty was rated using Grading of Recommendations Assessment, Development and Evaluation. Results: Five reviews (κ=100; n=8631) and 28 supplementary trials (knee/hip κ=23, hand κ=3, ankle κ=2; n=4360) were included. Evidence indicated small, short-term effects of exercise versus placebo (mean difference −10.8, 95% CI −19.1 to −2.6) and no-treatment (−12.4, 95% CI −15.6 to −9.2) for knee osteoarthritis pain, but certainty was very low and effects in larger or longer-term trials were smaller. Moderate evidence suggested negligible effects in hip (−6.7 95% CI −9.3 to −4.0) and small effects in hand (−10.0 95% CI −15.5 to −4.5) osteoarthritis. Varying certainty evidence indicated comparable outcomes to education, manual therapy, analgesics, injections and arthroscopy. Single trials in selected populations showed exercise was less effective than knee osteotomy (12.4 95% CI 4.7 to 20.2) and joint replacement (knee 17.1 95% CI 10.4 to 23.8; hip 24.2 95% CI 18.2 to 30.2) at longer term. Conclusion and relevance: Evidence on exercise for osteoarthritis remains largely inconclusive, suggesting negligible or short-lasting small effects comparable to, or less effective than, other treatments. These findings question its universal promotion and highlight the need to revisit research priorities and clinical discussions around its worthwhileness. Registration: CRD42023446888.
Top Cited PapersOpen AccessEffectiveness of exercise therapy for osteoarthritis: an overview of systematic reviews and randomised controlled trials
Objective: To provide an overview of the effects of exercise for osteoarthritis. Design: Overview. Data sources: Medline, Embase, Epistemonikos, PEDro, Cochrane and registries from inception to 8 November 2025. Eligibility criteria: Reviews comparing exercise with placebo, no intervention or other interventions on pain and function for osteoarthritis. Supplementary trials were included to update inconclusive areas. Data extraction and synthesis: Two independent reviewers extracted data and assessed bias. Data were standardised to a 0–100 scale and reanalysed using random-effects meta-analysis. Certainty was rated using Grading of Recommendations Assessment, Development and Evaluation. Results: Five reviews (κ=100; n=8631) and 28 supplementary trials (knee/hip κ=23, hand κ=3, ankle κ=2; n=4360) were included. Evidence indicated small, short-term effects of exercise versus placebo (mean difference −10.8, 95% CI −19.1 to −2.6) and no-treatment (−12.4, 95% CI −15.6 to −9.2) for knee osteoarthritis pain, but certainty was very low and effects in larger or longer-term trials were smaller. Moderate evidence suggested negligible effects in hip (−6.7 95% CI −9.3 to −4.0) and small effects in hand (−10.0 95% CI −15.5 to −4.5) osteoarthritis. Varying certainty evidence indicated comparable outcomes to education, manual therapy, analgesics, injections and arthroscopy. Single trials in selected populations showed exercise was less effective than knee osteotomy (12.4 95% CI 4.7 to 20.2) and joint replacement (knee 17.1 95% CI 10.4 to 23.8; hip 24.2 95% CI 18.2 to 30.2) at longer term. Conclusion and relevance: Evidence on exercise for osteoarthritis remains largely inconclusive, suggesting negligible or short-lasting small effects comparable to, or less effective than, other treatments. These findings question its universal promotion and highlight the need to revisit research priorities and clinical discussions around its worthwhileness. Registration: CRD42023446888.
- Open Access
- 27 January 2026
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (5) , 721-731
Defining and interpreting between-group differences in clinical trials of patients with osteoarthritis: Challenges and potential solutions
- 27 January 2026
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (5) , 721-731
Open AccessDefining and interpreting between-group differences in clinical trials of patients with osteoarthritis: Challenges and potential solutions